Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps

On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.The medical device company reported sales of $2.63 billion. That’s up 5% year over year on both a reported and operational basis, beating the consensus of$ 2.59 billion.The management expected Q1 sales growth of 3%-4% on a reported basis and approximately 4% on an operational basis.Companywide top-line performance on bot ...